Azenta, Inc. (AZTA)

Nasdaq Health Care Life Sciences Tools & Services S&P SmallCap 600
$39.16
+1.78 (+4.76%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Tue, Nov 10, 2026
After market close · quarter ending Sep/2026
Consensus EPS estimate
—
1 analysts · year-ago EPS $0.21
Trailing 12-month EPS
$-2.67
Diluted, last four reported quarters

Latest results, in brief

All AZTA 8-K briefs →
Aug 4, 4:32 PM ET

Azenta Q3 revenue rises 12% to $161 million; full-year revenue guidance narrowed

Mixed earnings Written later 2.02

Azenta reported third-quarter fiscal 2026 revenue from continuing operations of $161 million, up 12% from a year earlier, with organic growth of 9%. Continuing-operations diluted EPS was $(0.03) versus $(0.01) a year ago, and the company narrowed its full-year revenue and adjusted EBITDA ranges, so shareholders see higher sales alongside a wider per-share loss from continuing operations.

  • Revenue was $161 million, up 12% year over year; organic revenue rose 9%, and Sample Management Solutions revenue rose 14% to $88 million.
  • Diluted EPS from continuing operations was $(0.03) versus $(0.01) a year earlier; total diluted EPS was $0.05; non-GAAP diluted EPS was $0.16 versus $0.17.
  • Full-year fiscal 2026 revenue guidance is $613 million to $618 million, versus prior $603 million to $621 million; adjusted EBITDA guidance is $59 million to $62 million.
  • As of June 30, 2026, the company had repurchased $50.0 million of stock under a $250 million program authorized December 8, 2025.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Jun 2026$161.18M+12.0% $0.05— $2.46M1.5%
Mar 2026$144.79M+1.0% $-3.49— -$160.80M-111.1%
Dec 2025$148.64M+0.8% $-0.34— -$15.43M-10.4%
Sep 2025$159.19M+5.7% $1.11— $50.88M32.0%
Jun 2025$143.85M-0.3% $-1.05— -$47.99M-33.4%
Mar 2025$143.34M+5.1% $-1.04— -$47.66M-33.3%
Dec 2024$147.44M+3.7% $-0.25— -$10.99M-7.5%
Sep 2024$150.60M+156.3% $-0.14-450.0% -$6.64M-4.4%

From Azenta, Inc.'s 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$593.82M+3.6% $-1.22—-9.4%
FY2024$573.45M+4.0% $-3.10—-28.8%
FY2023$551.49M-0.7% $-0.22-100.8%-2.7%
FY2022$555.50M+8.1% $28.48+1811.4%384.0%
FY2021$513.70M+32.2% $1.49+69.3%21.6%

Frequently asked questions

When is Azenta's next earnings date?

Azenta (AZTA) is scheduled to report on Tuesday, November 10, 2026 after the market closes.

What did Azenta earn last quarter?

For the quarter ended Jun 2026, Azenta reported diluted EPS of $0.05 on revenue of $161.18M (+12.0%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.